Pfizer blood cancer meds given OK for use by US FDA

WASHINGTON D.C.: The US Food and Drug Administration has approved Pfizer's therapy for patients suffering multiple myeloma blood cancer, which is difficult to treat.

The decision allows use of the medication, branded as Elrexfio, in patients with recurring multiple myeloma.

Elrexfio, also known as elranatamab, belongs to a class of therapies known as bispecific antibodies, which assists the body's immune